Skip to main content
See every side of every news story
Published loading...Updated

Gilead Sciences (NASDAQ:GILD) Earns "Overweight" Rating from Cantor Fitzgerald

Summary by marketbeat.com
Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $155.00 price target on shares of Gilead Sciences in a report on Tuesday.

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

marketbeat.com broke the news on Tuesday, June 16, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal